Paris (20 Fevrier 2024)
Asklepios Advisors, a leading healthcare focused investment bank dedicated to growth companies, today announces the appointment of Helene Moore as an Operating Partner in North America.
The Asklepios team, sees this latest senior addition to the team as an important step to grow its
footprint in the Healthcare Consumer and Biopharma practices over the coming years with a local presence in North America.
Helene Moore is a seasoned dynamic Healthcare executive with substantial experience in the North American, European and Japanese markets as she occupied Senior positions in Business development, Sales, Marketing and General Management respectively for Bayer, Ethypharm, Acerus Pharma and Aurora Group.
She has notably led deals in Pharmaceuticals, Biotech, Medical Devices and Healthcare IT.
Hélène holds a Bachelor Degree in Biochemistry from Université de Montréal, executive MBA from Université du Québec à Montréal and an International Management Certification from the INSEAD
Dr. Edouard Gobitz, Managing Partner at Asklepios, commented: “We are delighted to welcome
Helene in the team. His appointment highlights our growth ambitions and we are convinced that his
arrival will be a great asset to our current setup across the globe.”
